Evidence map›Paper›PMID 11438682›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.

U Fuchs, G Rehkamp, O A Haas, R Slany, M Kōnig, S Bojesen, R M Bohle, C Damm-Welk, W D Ludwig, J Harbott and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Article
  3. Adaptor protein Abelson interactor 1 in homeostasis and disease.Cell communication and signaling : CCS · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Attachment of rod-like (BAR) proteins and membrane shape.Mini reviews in medicinal chemistry · 2011
    Review
  12. Article
  13. Article
  14. The F-BAR protein family Actin' on the membrane.Communicative & integrative biology · 2010
    Article
  15. Review
  16. Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells.International journal of clinical and experimental pathology · 2009
    Article
  17. Article
  18. Article
  19. Article
  20. Molecular pathogenesis of MLL-associated leukemias.International journal of hematology · 2005
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

U FuchsDepartment of Pediatric Hematology and Oncology, University of Giessen, 35392 Giessen, Germany.
G Rehkamp
O A Haas
R Slany
M Kōnig
S Bojesen
R M Bohle
C Damm-Welk
W D Ludwig
J Harbott
A Borkhardt
University of Chicago Medical Center · USRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have cloned a fusion partner of the MLL gene at 11q23 and identified it as the gene encoding the human formin-binding protein 17, FBP17. It maps to chromosome 9q34 centromeric to ABL. The gene fusion results from a complex chromosome rearrangement that was resolved by fluorescence in situ hybridization with various probes on chromosomes 9 and 11 as an ins(11;9)(q23;q34)inv(11)(q13q23). The rearrangement resulted in a 5'-MLL/FBP17-3' fusion mRNA. We retrovirally transduced murine-myeloid progenitor cells with MLL/FBP17 to test its transforming ability. In contrast to MLL/ENL, MLL/ELL and other MLL-fusion genes, MLL/FBP17 did not give a positive readout in a serial replating assay. Therefore, we assume that additional cooperating genetic abnormalities might be needed to establish a full malignant phenotype. FBP17 consists of a C-terminal Src homology 3 domain and an N-terminal region that is homologous to the cell division cycle protein, cdc15, a regulator of the actin cytoskeleton in Schizosaccharomyces pombe. Both domains are separated by a consensus Rho-binding motif that has been identified in different Rho-interaction partners such as Rhotekin and Rhophilin. We evaluated whether FBP17 and members of the Rho family interact in vivo with a yeast two-hybrid assay. None of the various Rho proteins tested, however, interacted with FBP17. We screened a human kidney library and identified a sorting nexin, SNX2, as a protein interaction partner of FBP17. These data provide a link between the epidermal growth factor receptor pathway and an MLL fusion protein.

Indexed as

Chromosomes, Human, Pair 9Proto-OncogenesTranscription FactorsVesicular Transport ProteinsArtificial Gene FusionBase SequenceCarrier ProteinsCell NucleusCell Transformation, NeoplasticChromosome MappingDNA-Binding ProteinsDNA, ComplementaryFatty Acid-Binding ProteinsHistone-Lysine N-MethyltransferaseHumansInfantCarrier ProteinsDNA-Binding ProteinsDNA, ComplementaryFatty Acid-Binding ProteinsFNBP1 protein, humanHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinTranscription FactorsVesicular Transport Proteins

Identifiers

PMID11438682
PMCPMC37508
OpenAlexW2129995506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.